H. Havsteen, MD
H. Havsteen, MD
TBD
Herlev Hospital, Oncology
TBD
Herlev
Denmark
TBD
Papers:
2 - Seminal Abstract
ICON 7: Final overall survival results in teh GCIG phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer